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Abstract—The development of natural ingredients use for conventional medicine is now in high requirement due to the 
traditional drugs are reasonably undemanding to be achieved. Annonaceae is one plant family which is usually utilized 
as medical plants in Indonesia and many other countries. One species of the family which is regularly used as customary 
medicine is A. muricata Linn which is well-known as soursop that comes from Caribbean, Central America, and South 
America. Along with the technological advancement, compounds and efficacy of soursop plant becomes popular. Annona 
muricata Linn. or soursop belongs to the Annonaceae family that is traditionally used to treat various diseases, such as cancer, 
diarrhea, convulsive, fungal and itching. The purpose of this study was to isolate and purify secondary metabolites of ethyl acetate 
fraction of the soursop stem bark. Research methods include extraction (maceration), fractionation and BLST test against Artemia 
salina. The structure of the 17.18-dihydroxy montecristin compound was determined by IR, 1H and 13C-NMR spectra HMBC and 
COSY. The compound had an activity to the tumor cell of murine leukemia cells P-388 with the IC50 value of 34.05 mg/mL 
respectively. This study found that the compound of 17.18-dihydroxy montecristin have been isolated from the stem bark of A. 
Muricata L. which has potential as an anticancer with the IC50 of 34.05 µg/mL. 
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I. INTRODUCTION 
The development of the use of natural ingredients for 
traditional medicine is currently in high demand. This is 
because traditional drugs are relatively easy to be obtained. 
Plants can manipulate a wide range of their chemical 
compounds as a mechanism to maintain their life to the 
environmental conditions, such as climatic factors, insects, 
and pests. Plants produce a variety of abundant class of 
organic compounds where most of the compounds do not 
appear directly in the growth and development of plants. The 
plant used as herbal medicines done by people just at the 
same time people make their civilization and traditional 
medicines are still crucial for treating by habit. Nowadays, 
developing countries which has a lack of health services still 
use folk medicines even without the scientific examination. 
These chemical substances are simply referred to as 
secondary metabolites, where their presences are limited to 
specific species in the plant kingdom. The compounds 
include alkaloids, acetogenins, and phenolic compounds [1]  
Annonaceae is one family of plant that is usually utilized 
as medicinal plants in various countries including Indonesia. 
There are 126 genera and 2500 species of the family [2], [3]. 
One species of the family is often used as traditional 
medicine is A. muricata Linn known as soursop that comes 
from Caribbean, Central America, and South America. By 
the development of technology, compounds and efficacy of 
soursop plant began to be known. Research on this plant 
have been done, including the discovery of alkaloids in the 
leaves and seeds of soursop [4], the content of the 
antioxidant, anti-inflammatory, antimicrobial, wound 
healing, antiulcerogenic activity, anti-protozoal, anticancer, 
insecticides in the ethanol extract of leaves of the soursop 
[1] , [5]–[11]. Luna et al. [12] reported that the extract of A. 
muricata leaves with polar solvent had the toxicity activity 
to larvae of the brine shrimp Artemia salina with the LC50 
of 0.49 µgmL-1. Two compounds, murihexocin A and B 
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were also isolated from A. muricata leaves showing 
significant inhibitory effects for tumor cell with selectivity to 
the prostate (PC-3) and pancreatic (PACA- 2) cells [13]. 
The ethyl acetate extract of A. muricata leaves had 
chemopreventive properties on azoxymethane-induced 
colonic aberrant crypt foci in rats [14]. It was also reported 
ethnobotanically that A. Muricata had cytotoxic activity [15]. 
The aqueous leaf extract of this plant has shown 
hepatoprotective and gastroprotective activities [16]. 
Antibacterial activities were also reported by several 
researchers [17-19]. Theoretically, chemical compounds that 
are bioactive in higher plants can be found in all parts of the 
plant [20]. Therefore, other classes of compounds such as 
flavonoids, steroids, and alkaloids can also be found on the 
bark of A. Muricata L.  
Traditionally, the use of A. muricata drug has been 
identified in the tropics to treat various diseases such as 
fever, pain, respiratory and skin diseases, parasites (internal 
and external),  infections caused by bacteria, hypertension, 
inflammation, diabetes, and cancer. It has been reported that 
the plant consisted of more than 200 chemical compounds. 
The most important are alkaloids, phenols, and acetogenins. 
Using the vitro study, extracts and phytochemicals from A. 
muricata have been characterized as an antimicrobial, anti-
inflammatory, anti-protozoal, antioxidants, and insecticides 
[4]. 
A. muricata L., also known as soursop is the member of 
Annonacea that has 130 genera, which leads to 2300 species. 
Some of them were found in America by the number 51,2 
from Africa and one in Asia [7]. The Annonaceae family in 
Brazil is found to comprise about 29 genera and 260 species 
found in all natural formations, especially Xylopia, Annona 
(genus) and Polyalthia (genus input). Only five genera of 
Annona, Rollinia, Uvaria, Melodorum, and Asimina are 
known to produce edible fruits, and many of these plants are 
commonly used in traditional medicine. Annonaceae and all 
the woody plants of Magnoliales are rich in chemical 
characteristics and are recognized as terpenoid sources 
(mainly terpenes), alkaloids (in large quantities, especially 
isoquinoline derivatives), steroids, polyphenols and 
flavonoids [21]. 
People in various parts of the world use soursop leaf (A. 
muricata Linn) to overcome various diseases. In Haiti, 
soursop leaves are used to overcome the problem of cough, 
diarrhea, fever, flu, heart, lactation, fleas, parasites, wounds, 
seizures, weakness and tranquilizers. In Africa, the leaves 
are utilized in reducing fever in children. In Brazil, they are 
used to treat ulcers, bronchitis, heart, diabetes, diarrhea, 
dysentery, fever, intestinal parasites, wounds, and intestinal 
worms. In Mexico, they are used to cure diarrhea, dysentery, 
fever, gum disease and reduce bleeding and in Ecuador, they 
are used as an analgesic [13]. 
Central America and South America. Along with the 
development of technology, content and efficacy of soursop 
plant began to unfold. Various studies show that the soursop 
plant contains many properties as medicines. Soursop plant 
parts, ranging from leaves, flowers, fruits, seeds, root, and 
bark can be used as a drug. In general, the parts of the 
soursop plant widely used to treat diseases such as 
hypertension, diabetes, cough, fever, ulcers, and other 
diseases [20]. Soursop plants are plants with a variety of 
health benefits. This plant can be used as a medicine to cure 
various diseases, ranging from mild illness such as itching of 
the skin to severe diseases such as tumors and cancer. In 
addition to cure cancer, soursop fruit also acts as an 
antibacterial, antifungal effective against various types of 
parasites/worms. Soursop leaves contain active ingredients, 
such as saponins, flavonoids, and tannins. As drugs made 
from plant material, it will be safer if consumed [2]. 
Compounds on soursop leaves that are suspected to have 
antidiabetic properties are alkaloid and flavonoid 
compounds. Flavonoid compounds are present in all parts of 
plants including leaves, roots, wood, skin, pollen, flowers, 
fruits, and seeds. Soursop fruit is commonly used to treat 
diseases caused by worms and parasites, treat fevers, 
increase milk production in nursing mothers, for diarrhea 
and dysentery. The crushed seeds can be used as vermifuge 
and anthelmintic against internal and external parasites and 
worms [22]. 
Research on this plant have been done, including the 
discovery of alkaloids in the leaves and seeds of soursop 
[23], the content of the antioxidant and anti-inflammatory in 
the ethanol extract of leaves of the soursop [24]. Compounds 
of flavonoids were also found in the chloroform extract of 
meat soursop, and the extract of n-butanol soursop leaves 
was an active compound that can lower uric acid levels [25]. 
Flavanoid compounds were also found in the chloroform 
extract of soursop fruit flesh, and the n-butanol extract of the 
leaves was an active compound that can lower uric acid 
levels [3]. The ethanol extract of the leaves produced 
leucoanthocyanins having nature toxicity to larvae 
Aedesaegypti. Thus, the extract contained a compound that 
can be used as a medicine for dengue fever [26]. The 
methanol extract compounds consisted of kaempferol that is 
potential as anti-cancer [27]. A previous study on the ethyl 
acetate fraction of the stem bark of A. Muricata shown that 
the fraction was active against A. Salina Lach with the LC50 
of 16.6 ppm [28-29]. This result indicates that there will be 
bioactive compounds in the fraction.  
Based on the above reason, further research was 
conducted on the isolation and test of the bioactivity toward 
murine leukemia cells P-388 of secondary metabolites in the 
ethyl acetate extract of the bark of the soursop (A. muricata 
Linn). From the literature search, it was clear that the 
potential of secondary metabolites found in plants soursop 
bark can be used as the active compound using a solvent of 
ethyl acetate.  
II. MATERIALS AND METHOD 
A Fisher John melting point apparatus was used to 
determine the melting point of the solid compounds obtained 
from the extract. was determined with. The infrared spectra 
were obtained with Prestige 21 Shimadzu FTIR 
spectrophotometer, whereas 1H NMR spectra and 13C were 
taken using (500 MHz) and (125 MHz) NMR was obtained 
by Agilent spectrophotometer using a DD2 console system. 
A. Materials 
The material used was the stem bark of A. muricata L., 
obtained from Pinrang, West Sulawesi. The sample was 
determined in Herbarium Bogoriene, Biological Research, 
and Development Center, LIPI Bogor. 
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B. Isolation and Purification 
The stem bark of A. muricata L was dried under air. The 
dried stem was cut to small pieces and powdered. The fine 
powder of A. muricata stems as many as 2.5 kgs was 
macerated by using methanol as a solvent for 3x24 h. The 
extract obtained was concentrated by using an evaporator 
until approximately a quarter of the total volume of the 
extract left. Furthermore, the concentrated extract obtained 
was portioned with ethyl acetate using a separation funnel. 
The filtrate was then evaporated until 15.48 g of the ethyl 
acetate extract was obtained. Before fractionation, the 
extract was firstly analyzed with Thin Layer 
Chromatography (TLC) and spots obtained were detected by 
a UV lamp and sprayed with a solution of 1.5 % of cerium 
sulfate.  
In addition, the TLC plate was heated until the spot 
appears to determine the suitable eluent to be used in 
fractionation. The ethyl acetate extract consisting of several 
compounds was fractionated by Vacuum Liquid Column 
Chromatography using silica gel 60 GF254 Merck 7730 as a 
stationary phase, and eluent of n-hexane, ethyl acetate : 
hexane, ethyl acetate, acetone : ethyl acetate, acetone, 
methanol with the increasing polarity order. The 
fractionation produced 40 fractions in the TLC plate using 
the same eluent. Spots with the same an Rf value were 
combined until 8 main fractions were obtained (A-H). All 
fractions were evaporated until a solid phase was produced.  
The main fraction of D as many as 3.0110 g was further 
fractionated by flash column chromatography to separate 
compounds obtained from Vacuum Liquid Column 
Chromatography. Eluents used were n-hexane, ethyl acetate: 
n-hexane, ethyl acetate, and acetone: ethyl acetate, acetone, 
methanol to produce 20 fractions. Combination fractions 
obtained and monitored by the TLC produced 8 fractions 
(D1-D8). The Fraction of D3 was further fractionated by 
flash column chromatography using eluents with the 
increase in polarity to produce 23 fractions. After 
combination, 9 fractions was obtained (D3.1-D3.9). The 
Fraction of D3.4 was evaporated and a white isolate as many 
as 0.5769 g was obtained. The isolate was crystallized and 
recrystallized to obtain a white crystal as many as 77.1 mg. 
The purity of the isolate was tested by thin layer 
chromatography using three different eluents; ethyl acetate: 
acetone (8:2), chloroform: methanol (9:1), and ethyl acetate: 
methanol (9:1) to ensure that the compound obtained was 
pure. The pure isolate had a melting point of 70-72oC, and 
then identified as compound of 17.18-dihydroxy 
montecristin. 
C. P-388 Test 
Bioassay using murine leukemia P-388 cells. P-388 
cancer is cultured in an RPMI-1640 medium given 5% calf 
serum and kanamycin (100 μg/mL). Cells (3x3 cells/wells) 
bred in 96 well plates consisting of 1001 growth mediums 
per well and incubated at 37oC in an incubator. Several 
variations of the compound (10 μL) were added to culture on 
the first day after transplantation. On the third day, 20 μl of 
MTT solution (5 mg/mL) per well was added to each culture 
medium. After 4 hours of incubation, 100 mL of 10% SDS 
in 0.01 N HCl solution was added to each well and the 
formazan crystals in each well were dissolved by stirring 
with a pipette. Afterward, the solution was measured 
optically densitically using a microplate reader (Tohso 
MPR-A4i) or ELISA reader at wavelengths of 550 and 700 
nm. The experiment was performed with three times of 
measurement. 
The anti-cancer activity was conducted by using murine 
leukemia cells P-388 as follows: a series of sample 
concentration was made and put into murine leukemia cells 
P-388. The cell was incubated for 48 h and a chromogenic 
reagent was then added and incubated for 4 h. After addition 
of a stopping growth reagent, the number of murine 
leukemia cells P-388 inhibited by the sample was measured 
by a microplate reader at a wavelength of 540 nm. The IC50 
was determined from the data obtained. The compound of 
17.18-dihydroxy montecristin had an activity to the tumor 
cell of murine leukemia cells P-388 with the IC50 value of 
34.05 mg/mL. 
III. RESULTS AND DISCUSSION 
The compound of 17.18-dihydroxy montecristin was 
white-colored powder, with a melting point of 70-72°C and 
weighs 77.1 mg. Figure 1 shows the FT-IR of the compound. 
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Fig 1. FT-IR spectrum of 17.18-dihydroxy montecristin 
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It is clear that there are absorption bands at 3346 and 
3080 cm-1 indicating the existence of free -OH group. This 
bonding vibration is thought to be the vibration of the –OH 
group that is undergoing intermolecular hydrogen bonding, 
which is supported by the bending vibration at 1070 cm-1 
for the stretching vibration of C–O. Other absorption bands 
are observed at 2918 and 2848 cm-1 for aliphatic C- H that 
supported by bands at 1467 cm-1 (-CH2) and 1382 cm-1 (-
CH3). The absorption bands at 1739; 1664 cm-1 belong to 
the C=O group. 
Analysis of 1H-NMR spectroscopy data showed typical 
signals, including 3 proton signals of alkenes at δ 7.27 ppm 
(H-35, d) for proton alkene in the cyclic unit, at δ 5.41 ppm 
(H-21, m) and δ 5.36 (H-22 m) for the proton of the open-
chain alkene. The cyclic unit forming the structure of γ-
lactone was shown by the proton signal at δ 5.02 ppm (H-36, 
m) for the proton of methine binding the cyclic oxy group 
(C-O-). Furthermore, there are 4 signals at δ 2.80 ppm (H-13, 
m); δ 2.84 ppm (H-14, m); δ 3.42 ppm    (H-17,m); and δ 
3.35 ppm (H-18, m) that indicate protons of methine 
substituted by hydroxyl groups. Two signals at     δ 0.87 ppm 
(H-34, t) and δ 1.40 ppm (H-37, d) are for methyl protons in 
the open-chain and bound to the cyclic structure, 
respectively. Other signals (24 signals) are signals for 
methylene groups (-CH2-). The proton signals indicate a 
framework of acetogenin compound (polyketide). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. 1H-NMR spectrum of 17,18-dihydroxy montecristin 
 
Analysis of 13C-NMR spectroscopy data showed 37 
carbon signals, which include a carbonyl (C-1) lactone at δ 
173.03 ppm; two carbon cyclic alkene at δ 133.15 ppm (C-2) 
and δ 149.88 ppm (C-35); two open-chain alkene carbon at δ 
129.64 ppm   (C-21) and δ 129.78 ppm (C-22); five oxy-
carbon at δ 77.13 ppm (C-36), δ 73.22 ppm (C-13), δ 73.34 
ppm (C-14), δ 73.65 ppm (C-17) and δ 73.75 ppm (C-18); 
and two methyl signals at δ 13.48 ppm (C-34) and δ 18.57 
(C-37), and 24 signals for methylene (-CH2-) groups. 
Bonding relationship structure was proved through a 
remote correlation of 13C-1H and a spectrum of HMBC 
showed the correlation distance between carbon and proton 
signals, carbonyl carbon at δ 173.03 ppm (C-1) with a proton 
at δ 2.23 ppm (H-3); δ 73.22 ppm (C-13) with δ 1.44 ppm 
(H-12). The complete data can be seen in Table 1. 
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Fig 3. 13C-NMR spectrum of 17,18-dihydroxy montecristin 
 
TABLE I 
1H, 13C, AND 2D NMR SPECTRUM OF THE COMPOUND 
Atom no. 1H-NMR 13C-NMR HMBC         (CH) COSY  (H-H) 
1 - 173.03 H-3  
2 - 133.15 H-3  
3 2.23 ( t )   25.75  H - 4 
4 1.55 ( m )   27.31  H - 3 
5 – 11 / 25 - 31 1.29 – 1.38   22.45  - 29.65   
12 1.44 ( m )   33.33   
13 2.80 ( m )   73.22 H –12,   
H -15 
 
14 2.84 ( m )   73.34   
15 1.50 ( m )   33.45   
16 1.50 ( m )   33.40   
17 3.42 ( m )   73.65   
18 3.35 ( m )   73.75   
19 1.56 ( m )   33.28   
20 2.16 ( m )   23.44   
21 5.41 ( m ) 129.64   
22 5.36 ( m ) 129.78 H-23  
23 2.04 ( m )   26.89   
24 1.29 ( m )   29.60   
32 1.29 ( m )   31.75 H – 34  
33 1.29 ( m )   22.45 H -34 H -34 
34 0.87 ( t )   13.48  H -33 
35 7.27 ( d ) 149.88 H -3, H -37  
36 5.02 ( m )   77.13 H- 37  
37 1.40 ( d )   18.57   
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 Based on data from HMBC correlations, it can be 
concluded that the compound analyzed was 17,18-dihydroxy 
montecristin as given in Figure 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Compound structure of 17,18-dihydroxy montecristin. 
 
NMR data of 17,18-dihydroxy montecristin compound 
similar to the derivative compound of montecristin reported 
previously [12]. The presence of these compounds may be 
an additional reference in the search for acetogenin 
compounds in the Annonaceae plant, which may be involved 
in their biogenesis pathway.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. The structure of montecristin and 17,18-dihydroxy montecristin. 
 
IV. CONCLUSIONS 
The compound of 17,18-dihydroxy montecristin have 
been isolated from the stem bark of A. Muricata L. The 
compound is potential as an anticancer with the IC50 of 
34.05 µg/mL. 
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